Authors:
LIPP E
VONFELTEN A
SAX H
MULLER D
BERCHTOLD P
Citation: E. Lipp et al., ANTIBODIES AGAINST PLATELET GLYCOPROTEINS AND ANTIPHOSPHOLIPID ANTIBODIES IN AUTOIMMUNE THROMBOCYTOPENIA, European journal of haematology, 60(5), 1998, pp. 283-288
Citation: K. Mayer et al., MAY-HEGGLIN-ANOMALY - FURTHER INVESTIGATI ONS INTO THE PLATELET-FUNCTION DISORDER, Schweizerische medizinische Wochenschrift, 127(26), 1997, pp. 1134-1140
Citation: M. Hurlimannforster et al., QUANTITATION OF PLATELET-SPECIFIC AUTOANTIBODIES IN PLATELET ELUATES OF ITP PATIENTS MEASURED BY A NOVEL ELISA USING THE PURIFIED GLYCOPROTEIN COMPLEXES GPIIB IIIA AND GPIB/IX AS ANTIGENS/, British Journal of Haematology, 98(2), 1997, pp. 328-335
Citation: Mk. Peter et al., FACTOR-XI DEFICIENCY - DO PATIENTS WITH A BLEEDING TENDENCY HAVE OTHER HEMOSTATIC DEFECTS, Schweizerische medizinische Wochenschrift, 126(23), 1996, pp. 999-1005
Citation: Jh. Beer et al., ALLERGEN EXPOSURE IN ACUTE ASTHMA CAUSES THE RELEASE OF PLATELET-ACTIVATING-FACTOR (PAF) AS DEMONSTRATED BY THE DESENSITIZATION OF PLATELETS TO PAF, International archives of allergy and immunology, 106(3), 1995, pp. 291-296
Citation: A. Vonfelten, ACTIVATED PROTEIN-C (APC) RESISTANCE - ENHANCED RISK OF THROMBOSIS INPATIENTS WITH APC RESISTANCE COMBINED WITH REDUCED PROTEIN-S, Thrombosis and haemostasis, 73(6), 1995, pp. 1370-1370
Citation: Mk. Peter et al., FACTOR-XI DEFICIENCY - ADDITIONAL HEMOSTATIC DEFECTS ARE PRESENT IN PATIENTS WITH BLEEDING TENDENCY, Thrombosis and haemostasis, 73(6), 1995, pp. 1442-1442
Authors:
BEER JH
CLERICI N
BAILLOD P
VONFELTEN A
SCHLAPPRITZI E
BUCHI L
Citation: Jh. Beer et al., QUANTITATIVE AND QUALITATIVE-ANALYSIS OF PLATELET GPLB AND VON-WILLEBRAND-FACTOR IN LIVER-CIRRHOSIS, Thrombosis and haemostasis, 73(4), 1995, pp. 601-609
Citation: Eo. Meili et al., RECOMBINANT ACTIVATED FACTOR-VII (NOVOSEV EN(TM) NOVO-NORDISK) FOR HEMOSTASIS IN A PATIENT WITH AN ACQUIRED FACTOR-VIII INHIBITOR, Schweizerische medizinische Wochenschrift, 125(9), 1995, pp. 405-411
Citation: C. Hurzeler et A. Vonfelten, MONITORING OF THERAPEUTIC ANTICOAGULATION WITH HIGH-DOSE STANDARD HEPARIN, Schweizerische medizinische Wochenschrift, 124(17), 1994, pp. 712-719
Authors:
CASPAR CB
VONFELTEN A
WIDMER L
BURGER J
GMUR J
Citation: Cb. Caspar et al., 3-LINEAGE RESPONSE AFTER LONG-TERM THERAP Y FOR SEVERE APLASTIC-ANEMIA WITH RHUG-CSF - PLATELET-FUNCTION DISORDER AS PRELUDE TO A MYELODYSPLASTIC SYNDROME, Schweizerische medizinische Wochenschrift, 124(1-2), 1994, pp. 69-72
Authors:
TAKAMIYA O
KEMBALLCOOK G
MARTIN DMA
COOPER DN
VONFELTEN A
MEILI E
HANN I
PRANGNELL DR
LUMLEY H
TUDDENHAM EGD
MCVEY JH
Citation: O. Takamiya et al., DETECTION OF MISSENSE MUTATIONS BY SINGLE-STRAND CONFORMATIONAL POLYMORPHISM (SSCP) ANALYSIS IN 5 DYSFUNCTIONAL VARIANTS OF COAGULATION FACTOR-VII, Human molecular genetics, 2(9), 1993, pp. 1355-1359
Authors:
WUILLEMIN WA
FURLAN M
VONFELTEN A
LAMMLE B
Citation: Wa. Wuillemin et al., FUNCTIONAL-CHARACTERIZATION OF A VARIANT PREKALLIKREIN (PK-ZURICH), Thrombosis and haemostasis, 70(3), 1993, pp. 427-432
Authors:
HOFFMANN R
KOHLER A
PLATZ A
ROGGO A
BISCHOF T
VONFELTEN A",OTMARTRENTZ
Citation: R. Hoffmann et al., PREVENTION OF DEEP-VEIN THROMBOSIS (DVT) IN HIP-SURGERY - LOW-MOLECULAR-WEIGHT HEPARIN (SANDOPARIN(R)) VERSUS 3X5000 IU UF-HEPARIN - A RANDOMIZED PROSPECTIVE-STUDY, Thrombosis and haemostasis, 69(6), 1993, pp. 1055-1055
Authors:
ATTENHOFER C
VONFELTEN A
SCHUIKI E
AMANN FW
Citation: C. Attenhofer et al., CORRELATION OF ACTIVATED CLOTTING TIME DURING CORONARY ANGIOPLASTY WITH HEPARIN LEVELS AND HEPARIN COFACTOR-II, Circulation, 88(4), 1993, pp. 208-208
Authors:
BEER JH
RABAGLIO M
BERCHTOLD P
VONFELTEN A
CLEMETSON KJ
TSAKIRIS DA
KEHREL B
BRANDENBERGER S
Citation: Jh. Beer et al., AUTOANTIBODIES AGAINST THE PLATELET GLYCOPROTEINS (GP) IIB IIIA, IA/IIA, AND GPIV AND PARTIAL DEFICIENCY IN GPIV IN A PATIENT WITH A BLEEDING DISORDER AND A DEFECTIVE PLATELET COLLAGEN INTERACTION/, Blood, 82(3), 1993, pp. 820-829